Invention Grant
- Patent Title: Pyrazolyl-ureas as kinase inhibitors
-
Application No.: US15118708Application Date: 2015-02-13
-
Publication No.: US09884845B2Publication Date: 2018-02-06
- Inventor: Alistair Ian Longshaw , Euan Alexander Fraser Fordyce , Stuart Thomas Onions , John King-Underwood , Jennifer Diane Venable , Iain Walters
- Applicant: Respivert Limited , Topivert Pharma Limited
- Applicant Address: GB Buckinghamshire
- Assignee: Respivert Limited
- Current Assignee: Respivert Limited
- Current Assignee Address: GB Buckinghamshire
- Agency: McDermott Will & Emery LLP
- International Application: PCT/GB2015/050401 WO 20150213
- International Announcement: WO2015/121660 WO 20150820
- Main IPC: A61K31/4427
- IPC: A61K31/4427 ; C07D401/14 ; C07D409/14 ; A61K31/497 ; C07D401/12 ; A61K31/498 ; A61K31/5377 ; A61K31/541 ; A61K31/551 ; C07D413/14 ; C07D487/04
Abstract:
There are provided compounds of formula (I) as defined in the specification, which are p38 MAP kinase inhibitors for use as medicaments for the treatment inter alia of inflammatory diseases.
Public/Granted literature
- US20170057945A1 NOVEL COMPOUNDS Public/Granted day:2017-03-02
Information query
IPC分类:
